Forcyte Biotechnologies Analysis
What is Forcyte Biotechnologies?
Forcyte Biotechnologies specializes in mechanobiology, integrating genomics and pharmacology to enhance mechanical cell function for developing more effective therapies.
Product Features & Capabilities
- FLECS tissuoid contraction assays, FLECS single-cell contractility assays, custom FLECS substrate development, mechanobiology dataset, drug discovery platform for small molecules, mapping genomics and pharmacology to mechanical cell function.
Who are the founders of Forcyte Biotechnologies
IP
Ivan Pushkarsky
CEO and Co-founder
DD
Dino Di Carlo
Co-founder
Investors
- Y Combinator
- Milestone Partners
- Acequia Capital
- Jude Gomila
- Pioneer Fund
- Bali Venture Partners
- Sprint VC
Competitors Overview
Forcyte Biotechnologies operates in the mechanobiology sector, focusing on mapping genomics and pharmacology to mechanical cell function. Its main competitors include:
- Syd Labs: Founded in 2010, Syd Labs has a reported revenue of $10.5 million and focuses on biotechnological advancements, pa
Market Focus
Forcyte Biotechnologies primarily focuses on the biotechnology industry, specifically in the field of mechanobiology, which involves mapping genomics and pharmacology to mechanical cell function to develop more effective therapies.
See something that needs updating? Suggest edits to this profile.